Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02044627 | Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 | PHASE1 | COMPLETED | 6 | — | — | Dec 1, 2013 | Jan 1, 2014 | Feb 15, 2019 | 1 | United Kingdom |
using mass balance recovery
| Arm | Type | Description |
|---|---|---|
| 1 dose of [14C-ETC-1002] | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| [14C-ETC-1002] | DRUG | - |
Inclusion Criteria: * Healthy Male Volunteers * BMI 10-35 kg/m2 Exclusion Criteria: * Hx of CV, renal, hepatic, chronic respiratory or GI disease * Hx of drug or alcohol abuse * smoking within 12 mos of screening